Chronic cyclosporine nephrotoxicity in rheumatoid arthritis
Pei, Y.
Journal of Rheumatology 23(1): 4-5
1996
ISSN/ISBN: 0315-162X PMID: 8838500 Document Number: 462507
Document emailed within 1 workday
Related Documents
Mihatsch, M.J.; Steiner, K.; Abeywickrama, K.H.; Landmann, J.; Thiel, G. 1988: Risk factors for the development of chronic cyclosporine-nephrotoxicity Clinical Nephrology 29(4): 165-175Kumar, M.S.; Samhan, M.; John, P.; al-Adnani, M.S.; Abouna, G.M. 1989: Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation? Transplantation Proceedings 21(1 Part 2): 1552-1553
Feutren, G. 1988: Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type i diabetes trials Transplantation Proceedings 20(3 Suppl 4: 356-366
Gremese, E.; Ferraccioli, G.F. 2004: Benefit/risk of cyclosporine in rheumatoid arthritis Clinical and Experimental Rheumatology 22(5 Suppl 35: S101-S107
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Madhok, R.; Torley, H.I.; Capell, H.A. 1991: A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis Journal of Rheumatology 18(10): 1485-1489
Toma, H.; Tanabe, K.; Oba, S.; Horita, S.; Takahashi, K.; Teraoka, S.; Ota, K. 1987: Expression of class Ii antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity Transplantation Proceedings 19(5): 3719-3720
Jarner, D.; Jarlov, N.V.; Larsen, J.H. 1977: Yersinia arthritis and chronic collagenosis. II. Cases of Yersinia arthritis with prolonged course and development of rheumatoid arthritis Ugeskrift for Laeger 139(25): 1481-1484
Schaller, J.G. 1983: Chronic arthritis in children. Juvenile rheumatoid arthritis Clinical Orthopaedics and Related Research 53(182): 79-89
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Chan, P.; Chapman, J.R.; Morris, P.J. 1987: Glycosuria: an index of cyclosporine nephrotoxicity Transplantation Proceedings 19(1 Pt 2): 1780
van den Borne, B.E.; Landewé, R.B.; Goei The, H.S.; Rietveld, J.H.; Zwinderman, A.H.; Bruyn, G.A.; Breedveld, F.C.; Dijkmans, B.A. 1998: Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine Journal of Rheumatology 25(8): 1493-1498
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Jorkasky, D.; Audet, P.; Williams, S.; Grossman, R.; Conrad, M. 1987: Cyclosporine-induced nephrotoxicity: role of prostaglandins Transplantation Proceedings 19(1 Pt 2): 1742-1744
Chapman, J.R.; Morris, P.J. 1985: Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine Transplantation Proceedings 17(4 Suppl 1: 254-260
Smeesters, C.; Giroux, L.; Vinet, B.; Arnoux, R.; Chaland, P.; Corman, J.; St-Louis, G.; Daloze, P. 1988: Reduced nephrotoxicity of cyclosporine a after incorporation into liposomes Transplantation Proceedings 20(3 Suppl 3: 831-832
Martin, M.; Packham, D.; Kingswood, C.; Cairns, H.; Khaghani, A.; Thompson, D.; Yacoub, M. 1987: Determinants of cyclosporine nephrotoxicity following cardiac transplantation Transplantation Proceedings 19(1 Part 3): 2516-2517